Aspira Women's Health Inc.
AWHL- Exchange
- OTC
- Industry
- In Vitro & In Vivo Diagnostic Substances
- SEC CIK
- 0000926617
No open-market purchases or sales by Aspira Women's Health Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
Q1 2025 vs. Q4 2024
How the institutions holding Aspira Women's Health Inc. changed between Q4 2024 and Q1 2025.
All holders in Q1 2025All holders in Q4 2024
| Measure | Q4 2024 | Q1 2025 | Change |
|---|---|---|---|
| Holders | 26 | 25 | −1 |
| Shares | 1.46M | 864.2K | −592.9K (−40.7%) |
| Value | $1.03M | $81.0K | −$946.5K (−92.1%) |
New holders (3)
Institutions that held Aspira Women's Health Inc. at the end of Q1 2025 but not at the end of Q4 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| HRT Financial LP | 182,286 | $17.0K | 0.00% |
| XTX Topco Ltd | 62,184 | $5.84K | 0.00% |
| Royal Bank of Canada | 100 | $0 | 0.00% |
Sold out (4)
Institutions that held Aspira Women's Health Inc. at the end of Q4 2024 and filed for Q1 2025 without it.
| Institution | Shares, Q4 2024 | Value, Q4 2024 |
|---|---|---|
| Armistice Capital, LLC | 710,000 | $500.6K |
| Jane Street Group, LLC | 29,616 | $20.9K |
| Quantum Private Wealth, LLC | 21,799 | $15.4K |
| Global Wealth Strategies & Associates | 18 | $13 |